Skip to content

Breath Test for Biomarkers in Humans Receiving Total Body Irradiation

Breath Test for Biomarkers in Humans Receiving Total Body Irradiation

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02152722
Enrollment
30
Registered
2014-06-02
Start date
2013-09-30
Completion date
2016-11-30
Last updated
2015-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Radiation Injury

Keywords

Breath test, Volatile Organic Compounds, VOC, oxidative stress, radiation biodosimetry, metabolomics, GCxGC TOF-MS

Brief summary

The effect of radiation on normal tissue varies widely between individuals. Consequently, a test to measure tissue response to radiation could be clinically useful by permitting more accurate titration of dosage in patients undergoing radiotherapy. Also, in view of emerging concerns about possible nuclear terrorism a test for exposure to radiation might also be useful in evaluating victims of a dirty bomb explosion. A number of different techniques have been previously reported in epidemiological studies for the estimation of prior radiation exposure. This study explores one approach to estimating radiation exposure by measurement of increased oxidative stress which can be detected by a breath test. In this study subjects undergoing significant exposure to therapeutic radiation will provide breath samples for analysis in a central laboratory. The hypothesis of the study is that the analysis of these samples will lead to the identification of a set of markers of radiation exposure.

Interventions

None listed

Sponsors

Department of Health and Human Services
CollaboratorFED
Memorial Sloan Kettering Cancer Center
CollaboratorOTHER
Emory University
CollaboratorOTHER
Hackensack Meridian Health
CollaboratorOTHER
Menssana Research, Inc.
Lead SponsorINDUSTRY

Study design

Observational model
COHORT
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. Age 18 years or older 2. Subject is willing and able to cooperate with study and give signed informed consent to participate 3. Subject has been diagnosed with a condition that requires treatment with a TBI protocol of daily irradiation for one to five days 4. Actively smoking subjects, as well as never smokers and former smokers are eligible for the study so long as a complete smoking consumption history can be recorded 5. Subject will be available for follow-up breath tests following each session of TBI. Subjects receiving only one day of TBI will be available for a follow-up 24-36 hours following TBI 6. Subject is an in-patient at the hospital

Exclusion criteria

1\. Subject has had chemotherapy within preceding 21 days

Design outcomes

Primary

MeasureTime frameDescription
Radiation volatile organic compound (VOC) scoreEach day of radiation exposure at time points between 1 day and 7 days post exposure.An algorithm for scoring the radiation exposure based on analysis of breath samples will be developed and applied to each breath sample collected. The hypothesis is that the scores will indicate radiation exposure, specifically exposure to more than 2 Gray at time points between 1 day and 7 days post exposure.

Countries

United States

Contacts

Primary ContactMichael Phillips, MD
mphillips@menssanaresearch.com973-643-5464
Backup ContactPeter Kaplan, PhD
pkaplan@menssanaresearch.com973-643-5464

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026